| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | WO2000009149A1 Tnf-derived peptides for use in treating oedema |
| 02/24/2000 | WO2000009126A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | WO2000009109A2 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO2000009054A1 Indwelling heat exchange catheter and method of using same |
| 02/24/2000 | WO1999058098A8 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO |
| 02/24/2000 | WO1999045788A8 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 02/24/2000 | DE19837638A1 New arylsulfonamides and analogs, are cannabinoid receptor agonists used e.g. for treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | DE19837627A1 New aminoacid esters of arylsulfonamides are useful for e.g. treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | CA2821440A1 Intravascular heat exchange catheter with multiple heat exchange elements such as balloons |
| 02/24/2000 | CA2756625A1 Intravascular heat exchange catheter with multiple heat exchange elements such as balloons |
| 02/24/2000 | CA2607018A1 Indwelling heat exchange catheter and method of using same |
| 02/24/2000 | CA2553126A1 Oral sustained-release preparation of fasudil hydrochloride |
| 02/24/2000 | CA2344520A1 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | CA2340106A1 Purification of blood clotting proteins |
| 02/24/2000 | CA2340100A1 Novel sulfonyl derivatives |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2339779A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | CA2335813A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | CA2277242A1 Process for pyrrolidinyl hydroxamic acid compounds |
| 02/23/2000 | EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/23/2000 | EP0980367A1 Antithrombotic agents |
| 02/23/2000 | EP0980366A1 Antithrombotic agents |
| 02/23/2000 | CN1245504A Peptides and compounds that bind to receptor |
| 02/23/2000 | CN1049654C Piperazine derivatives and medicine composition containing same and use thereof |
| 02/22/2000 | US6028164 Bioresorbable compositions for implantable prostheses |
| 02/22/2000 | US6028090 Adhesion receptor antagonists III |
| 02/22/2000 | US6028056 Useful for in vivo detection and diagnosis of thrombi. the precursor reagents of the invention may also be used in production of antithrombotic agents derived from apcitide |
| 02/22/2000 | US6028051 Administering single dose of lysostaphin analogue and lysostaphin for treating endocarditis, bacterimia, kidney infection, lung infection, skin infection, bone infection, burn wound infections, infection of prosthetic devices |
| 02/22/2000 | CA2071630C Hybrid protein c |
| 02/22/2000 | CA2071625C A pharmaceutical preparation containing a thrombolytically active substance |
| 02/17/2000 | WO2000008014A1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 02/17/2000 | WO2000008007A2 Cyclopentabenzofuran derivatives and their use |
| 02/17/2000 | WO2000007659A1 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 02/17/2000 | WO2000007626A1 Use of anti-coagulation factor antibodies as long-lasting protective agents |
| 02/17/2000 | WO2000007625A1 Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells |
| 02/17/2000 | WO2000007591A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | WO2000007579A2 Use of cyclopentabenzofuran-derivatives for combating nf-$g(k)b-dependent diseases |
| 02/17/2000 | DE19836697A1 New substituted 4-amino-2-aryl-pyrimidines, are soluble guanylate cyclase activators useful e.g. for treating atherosclerosis, hypertension, angina pectoris, thrombosis, asthma or diabetes |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2338727A1 Indole spla2 inhibitors |
| 02/16/2000 | EP0979614A2 Method of producing iron-whey-proteolysate complex |
| 02/16/2000 | EP0979311A1 $i(IN VIVO) USE OF RECOMBINAGENIC OLIGONUCLEOBASES TO CORRECT GENETIC LESIONS IN HEPATOCYTES |
| 02/16/2000 | EP0979289A1 Human lysophospholipase |
| 02/16/2000 | EP0979240A1 Serine protease inhibitors |
| 02/16/2000 | EP0979077A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders |
| 02/16/2000 | CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase |
| 02/16/2000 | CN1244859A Benzenesulfonamide derivatives and drugs containing the same |
| 02/16/2000 | CN1244798A Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds |
| 02/16/2000 | CN1244426A Fast-acting nemostatic pellet |
| 02/16/2000 | CN1244411A Tiandihua liquid for promoting hemopoiesis |
| 02/16/2000 | CN1049434C Aromatic amidine derivatives and method for preparing medicinal salts thereof |
| 02/15/2000 | US6025472 N-substituted glycine derivatives as enzyme inhibitors |
| 02/15/2000 | US6025382 Antithrombotic diamines |
| 02/15/2000 | US6025373 Decreasing fibrinogen levels without undohypo-coagulation, |
| 02/15/2000 | US6025330 Inhibitors of fibrin cross-linking and/or transglutaminases |
| 02/15/2000 | US6025142 Hydrophobic u-PAR binding site |
| 02/15/2000 | US6024936 Antibody-based method of localizing activated thrombin receptors |
| 02/11/2000 | CA2280241A1 Method of producing iron-whey-proteolysate complex |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006709A1 Human protein kinase h2lau20 |
| 02/10/2000 | WO2000006705A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 02/10/2000 | WO2000006589A1 Prostate derived ets factor |
| 02/10/2000 | WO2000006570A1 Triazolopyridines for the treatment of thrombosis disorders |
| 02/10/2000 | WO2000006569A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 02/10/2000 | WO2000006568A1 Substituted pyrazole derivatives |
| 02/10/2000 | WO2000006567A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine |
| 02/10/2000 | WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT |
| 02/10/2000 | WO2000006147A1 Macrophage scavenger receptor antagonists |
| 02/10/2000 | WO2000006032A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 02/10/2000 | DE19835325A1 Verwendung von Cyclopentabenzofuran-Derivaten zur Bekämpfung von NF-kB abhängigen Krankheiten Use of cyclopentabenzofuran derivatives for the control of NF-kB-dependent diseases |
| 02/10/2000 | DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use |
| 02/10/2000 | CA2339094A1 Macrophage scavenger receptor antagonists |
| 02/10/2000 | CA2339071A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 02/10/2000 | CA2338654A1 Triazolopyridines for the treatment of thrombosis disorders |
| 02/10/2000 | CA2338396A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | CA2338019A1 Prostate derived ets factor |
| 02/10/2000 | CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335643A1 C7f2-a novel potassium channel .beta.-subunit |
| 02/09/2000 | EP0978517A2 Triazolopurines, process for their preparation and their use as medicaments |
| 02/09/2000 | EP0977773A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/09/2000 | EP0977772A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977741A1 Substituted phenyl derivatives, their preparation and use |
| 02/09/2000 | EP0977584A1 PHARMACEUTICAL PREPARATION COMPRISING vWF PROPEPTIDE |
| 02/09/2000 | EP0977582A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 02/09/2000 | EP0822934B1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
| 02/09/2000 | CN1244128A Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 02/09/2000 | CN1243708A Injection for treating thrombocytopenic purpura and its application |
| 02/08/2000 | US6022977 Dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids |
| 02/08/2000 | US6022898 Metalloproteinase inhibitors |
| 02/08/2000 | US6022535 Administering human interleukin-3 variant or mutant proteins (muteins) fused with other colony stimulating factors, cytokines, lyphokines, interleukins, hematopoietic growth factors; treating side effects of cancer radiation therapy |
| 02/08/2000 | CA2234364C Compositions for inhibiting platelet aggregation |
| 02/03/2000 | WO2000005269A1 Polymer complexes of glucuronoglucanes |